Back to Journals » Vascular Health and Risk Management » Volume 16

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

Total article views   HTML views PDF downloads Totals
3,910 Dovepress* 3,322+ 1,232 4,554
PubMed Central* 588 209 797
Totals 3,910 1,441 5,351
*Since 7 October 2020

View citations on PubMed Central and Google Scholar